贫血是慢性肾脏病常见并发症，肾性贫血的规范化治疗涉及到贫血监测、铁剂和红细胞生成素的合理应用、肾性贫血治疗的靶目标等方面。指南及共识对治疗存在重要指导意义，本文通过复习和回顾包括欧洲最佳指南(european best practice guidelines,EBPGs)、肾脏病预后质量指南(kidney disease outcome quality initiative,K/DOQI)改善全球肾脏病预后组织(kidney disease:improving global outcmes,K/DIGO)临床实践指南及英国国家卫生与临床优化研究所(national institute
for health and clinical excellence,NICE)等指南，为临床肾性贫血治疗提供指导。

Anemia is one of the common complications in chronic kidney disease patients. The standardized treatment of renal anemia relates to anemia monitoring, rational use of iron and erythropoietin, anemia treatment targets, etc. The guidelines and consensus are highly significant to renal anemia treatment. We aim
to provide clinicians with the advices through reassessment of the guidelines in EBPGs, K/DOQI, K/DIGO and NICE.